Neurodiversity in Tech with Dr. Joan Fallon

Recently named one of the top 100 Most Intriguing Entrepreneurs of 2020 by Goldman Sachs, Dr. Joan Fallon, Founder and CEO of Curemark, is considered a visionary scientist who has dedicated her life’s work to championing the health and wellbeing of children. Curemark is a biopharmaceutical company focused on the development of novel therapies to treat serious diseases for which there are limited treatment options. The pipeline includes a phase III clinical-stage research program for Autism, and programs focused on Parkinson’s Disease, schizophrenia, and addiction. Joan holds over 300 patents worldwide, has written numerous scholarly articles and lectured extensively across the globe on pediatric developmental problems. Currently she holds appointments as a Senior Advisor to the Henry Crown Fellows at The Aspen Institute, as well as a Distinguished Fellow at the Athena Center for Leadership Studies at Barnard College. She is also a member of the Board of Trustees of Franklin & Marshall College, The Pratt Institute, the DREAM Charter School in Harlem, the PitCCh In Foundation started by CC and Amber Sabathia, Springboard Enterprises ( venture catalyst that supports women–led growth companies) and Vote Run Lead, a bipartisan not-for-profit that encourages women on both sides of the aisle to run for elected office. She has testified before Congress on the matters of business and patents. In addition to the recent award by Goldman Sachs, Joan was named 2017 EY Entrepreneur Of The Year NY in Healthcare and received the Creative Entrepreneurship Award from The New York Hall of Science in 2018. An accomplished speaker, Joan’s talks cover the following topics: How Curemark is disrupting biotech and leading the way in treating autism, How to Build a Resilient Brand for the Future, Deductive or Inductive Reasoning - Accelerating Innovation and Don’t Let Disruption be Your STOP sign.